Shefali Agarwal
2020
In 2020, Shefali Agarwal earned a total compensation of $1.8M as Executive Vice President, Chief Medical and Development Officer at Epizyme, a 38% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $199,804 |
|---|---|
| Option Awards | $825,799 |
| Salary | $478,000 |
| Stock Awards | $274,990 |
| Other | $7,154 |
| Total | $1,785,747 |
Agarwal received $825.8K in option awards, accounting for 46% of the total pay in 2020.
Agarwal also received $199.8K in non-equity incentive plan, $478K in salary, $275K in stock awards and $7.2K in other compensation.
Rankings
In 2020, Shefali Agarwal's compensation ranked 6,042nd out of 13,090 executives tracked by ExecPay. In other words, Agarwal earned more than 53.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,042 out of 13,090 | 54th |
Division Manufacturing | 2,488 out of 5,621 | 56th |
Major group Chemicals And Allied Products | 997 out of 2,254 | 56th |
Industry group Drugs | 863 out of 1,954 | 56th |
Industry Pharmaceutical Preparations | 643 out of 1,459 | 56th |
Pay ratio
| Shefali Agarwal's Pay | $1,785,747 |
|---|---|
| Median Employee's Pay | $333,249 |
| Pay Ratio | 5to 1 |
In 2020, the annual total compensation of Shefali Agarwal was $1,785,747.
The annual total compensation of the median employee at Epizyme was $333,249.
The ratio of Shefali Agarwal's pay to the pay of median employee was therefore 5 to one.
Source: SEC filing on April 29, 2021.
Agarwal's colleagues
We found four more compensation records of executives who worked with Shefali Agarwal at Epizyme in 2020.